Scientific MOOCs follower. Author of Airpocalypse, a techno-medical thriller (Out Summer 2017)


Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!


Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.


I am an early adopter of scientific MOOCs. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs? Imagine all the people sharing their data...

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC (http://www.videolan.org) to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (http://www.videolan.org).


3D Printing: French Sci-Fi Writer's Giving His Heart Out

French Sci-Fi Writer Bernard Werber had the exact replica of his own heart printed out, with the help of a 3D printer...

Bernard Werber: "Mon vrai coeur en sculpture, fruit de la nouvelle technologie VIZUA sous l'oeil expert du maitre en sculpture 3 D sylvain Ordureau.
Merci Sylvain...
PS 1 : technologie Vizua par Sylvain Ordureau, radiologie Dr JF Paul, designer Omar Bouhelal Shirmer.
PS 2 : on l'a radiographié car il a des petites pannes du fait d'un bouchage d'une coronaire, mais je fais du sport.
PS 3: c'est avec ça que j'écris." (Facebook, 08/19/2013).

Aucun commentaire: